MicroPort® EP Obtains CFDA Approval for EasyFinder™ 3D Steerable Curve Mapping Catheter
Shanghai, China – Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP") recently obtained the regulatory approval from China Food and Drug Administration ("CFDA") for its in-house developed EasyFinder™ 3D Steerable curve mapping catheter.
The EasyFinder™ 3D catheter is indicated for use in cardiac electrophysioloty studies. When used with Columbus™ 3D EP Navigation System ("Columbus™") and External Reference Patch, it provides precise location of the catheter curve in the body. EasyFinder™ 3D catheter has a high-torque shaft with a deflectable curve section. The tip deflection is controlled at the proximal end by a handle. The high-torque shaft also allows the plane of the curved tip to be rotated to facilitate accurate positioning of the catheter tip at the desired site.
President of MicroPort® EP Yiyong Sun said: "The CFDA approval of EasyFinder™ 3D Steerable curve mapping catheter signifies a major step forward for MicroPort® EP to provide a complete electrophysiological solution for arrhythmia patients with combinations of active and passive devices and equipment."
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.